Early Redemption and Cancellation of 4th Series Convertible Bonds Worth 1.24 Billion Won
- SD BIOTECHNOLOGIES decided to acquire and cancel its 4th series unsecured private convertible bonds with a face value of 1.175 billion won at a total cost of 1.242 billion won (including interest) due to bondholders' exercise of put option.
- The convertible bonds were issued on December 20, 2023, with a conversion price of 500 won per share and a maturity date of December 19, 2028.
- The acquisition was funded with internal cash, and the acquisition date was June 22, 2026.
- After the acquisition, the total face value of the bonds is zero, completely eliminating existing debt and potential equity dilution.
ADVERTISEMENT (250px+)
KOSDAQ Filing Information
- Filing: Acquisition of Convertible Bonds (Including Overseas Convertible Bonds) Before Maturity After Issuance (4th Series)
- Company: SD BIOTECHNOLOGIES (217480)
- Submission: SD BIOTECHNOLOGIES CO., LTD.
- Receipt: 05-21-2026
- Under KRX KOSDAQ Market Division